<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>vaccine on FinanClub</title>
    <link>https://finan.club/tags/vaccine/</link>
    <description>Recent content in vaccine on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 08 Jan 2024 09:12:20 +0000</lastBuildDate><atom:link href="https://finan.club/tags/vaccine/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>PFE</title>
      <link>https://finan.club/us/pfe/</link>
      <pubDate>Mon, 08 Jan 2024 09:12:20 +0000</pubDate>
      
      <guid>https://finan.club/us/pfe/</guid>
      <description>score:152
Chances: Pfizer&amp;rsquo;s gene therapy for the treatment of a rare inherited bleeding disorder has been approved in Canada and is pending approval in the U.S., indicating potential positive developments in the company&amp;rsquo;s product pipeline. Pfizer&amp;rsquo;s acquisition of Seagen Inc. for $43 billion and its full-year 2024 revenue guidance suggest potential growth opportunities for the company in the coming years.</description>
    </item>
    
  </channel>
</rss>
